NDC 0378-1803-01 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-1803
- Requested NDC
- 0378-1803-01
- Package NDCs from labels
- 0378-1803-77, 0378-1803-10, 0378-1803-01
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2025-07-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - Mylan Institutional Inc. | Mylan Institutional Inc. | 2025-07-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2024-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - A-S Medication Solutions | A-S Medication Solutions | 2023-08-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2021-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - A-S Medication Solutions | A-S Medication Solutions | 2018-08-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - Physicians Total Care, Inc. | Physicians Total Care, Inc. | 2012-04-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Levothyroxine Sodium - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0378-1803-10 | Levothyroxine Sodium | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 31 | |
| 0378-1803-77 | Levothyroxine Sodium | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 31 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-1803-01 | EA - Each | 0378-1803 | c34b438c-d28e-4969-af35-98f2034ec6c6 | 1 | 2012-07-24 |
| 0378-1803-04 | EA - Each | 0378-1803 | 533ea635-f228-4638-ac5e-c93cc62acb1c | 1 | 2020-09-14 |
| 0378-1803-10 | EA - Each | 0378-1803 | 05daa8d3-2d0a-43e5-bb62-72b3740d38d5 | 1 | 2012-07-24 |
| 0378-1803-77 | EA - Each | 0378-1803 | cbe515a6-0588-484a-b4d6-1b6211f27956 | 1 | 2016-07-19 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SILICA MARINA | SILICON DIOXIDE | Boiron | 3aada26e-6a8e-f545-e063-6394a90a9f80 | 2025-07-24 | ETJ7Z6XBU4 | |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1a9ef9-9a54-5f94-e053-2a91aa0ab477 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Mylan Institutional Inc. | cd69c192-cd3f-47e6-b0a6-c536ffed5c4b | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | ANDA076187 966248 966270 966249 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | cfab474d-3272-41fd-a8ec-762dd1a84fa6 | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b9a50170-ac0b-483e-9e85-1d03b12e4f7d | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Mylan Institutional Inc. | 5723c7a7-2a1d-4ab6-bf39-b2165ae781a6 | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | ANDA076187 51079-441-01 51079-443-20 51079-445-01 51079-440-20 51079-442-20 51079-440-01 51079-443-01 51079-444-20 51079-441-20 51079-445-20 51079-442-01 51079-444-01 51079-441 51079-443 51079-444 51079-440 51079-442 51079-445 966222 892246 966221 966224 966220 966225 3a864332-4c4d-08a5-e063-6294a90aaaff 5723c7a7-2a1d-4ab6-bf39-b2165ae781a6 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 398a00d0-1247-4f6f-b4c1-dade399cc417 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70d84fe0-afc4-4ef2-b4d8-f156abac3d1f | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | ff7f5eff-4c90-4aa0-8915-704f92dea8aa | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | C151H8M554 ETJ7Z6XBU4 |
| DENTAL-CHORD | ACETICUM ACIDUM, AMMONIUM MURIATICUM, ARGENTUM METALLICUM, AURUM METALLICUM, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CARBOLICUM ACIDUM, CITRUS LIMONUM, CUPRUM METALLICUM, FERRUM METALLICUM, GLYCYRRHIZA GLABRA, LAPPA MAJOR, MEDULLA OSSIS SUIS, MERCURIUS SOLUBILIS, MYRRHA, NATRUM FLUORATUM, PALLADIUM METALLICUM, PHOSPHORICUM ACIDUM, PHYTOLACCA DECANDRA, SELENIUM METALLICUM, SILICEA, STANNUM METALLICUM, STAPHYSAGRIA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, X-RAY, ZINCUM OXYDATUM | Energetix Corporation | 6c9ba926-7c35-49fd-94d8-988ca0bb772c | 2025-07-15 | Warnings | ETJ7Z6XBU4 |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 412fc3f4-d9e0-49c5-b042-a6010aea7e5e | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Endocrinpath | ALFALFA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CEANOTHUS AMERICANUS, CITRICUM ACIDUM, FUCUS VESICULOSUS, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYDROCOTYLE ASIATICA, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, PANCREAS SUIS, PHYTOLACCA DECANDRA, PITUITARUM POSTERIUM (BOVINE), SARSAPARILLA (SMILAX REGELII), SILICEA, SYZYGIUM JAMBOLANUM, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corporation | 70f84941-b8a1-48f4-9c05-554e554f0049 | 2025-07-11 | Warnings | ETJ7Z6XBU4 |
| Schuessler Tissue Salts Silica 6X Cleanser and Conditioner 12 | SILICEA | Martin & Pleasance Pty Ltd | 39620db9-5099-47f0-93ad-c00e6625c462 | 2025-07-07 | Warnings | ETJ7Z6XBU4 |
| THYQUIDITY | LEVOTHYROXINE SODIUM | Oliva Therapeutics, LLC | 0c839877-50e4-455f-9b6c-462efb09cb96 | 2025-07-03 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 884f9fa1-58aa-4ff7-934f-106a0470e747 | 2025-07-03 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Arnica Calendula Wound | ARNICA CALENDULA WOUND | Uriel Pharmacy, Inc | 38cfd292-4dbd-2caf-e063-6394a90a0527 | 2025-06-30 | Warnings | ETJ7Z6XBU4 |
| Bac | APIS MELLIFERA, ARSENIC TRIOXIDE, ATROPA BELLADONNA, MATRICARIA CHAMOMILLA FLOWERING TOP OIL, LACHESIS MUTA VENOM, MERCURIUS SOLUBILIS, PULSATILLA VULGARIS WHOLE, TOXICODENDRON PUBESCENS LEAF, AND SILICON DIOXIDE | Zorex | 7ae38e0c-8e74-4fd5-8605-45e424a84d01 | 2025-06-30 | Warnings | ETJ7Z6XBU4 |
| Bambusa Aurum | BAMBUSA AURUM | Uriel Pharmacy Inc. | 43f3dd30-701f-4fa4-9743-d10051c6e6d4 | 2025-06-27 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.